{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T10:02:33Z","timestamp":1784800953608,"version":"3.55.0"},"reference-count":138,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003093","name":"Ministry of Higher Education, Malaysia","doi-asserted-by":"publisher","award":["MO002D-2021"],"award-info":[{"award-number":["MO002D-2021"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003093","name":"Ministry of Higher Education, Malaysia","doi-asserted-by":"publisher","award":["MO002D-2021"],"award-info":[{"award-number":["MO002D-2021"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003093","name":"Ministry of Higher Education, Malaysia","doi-asserted-by":"publisher","award":["MO002D-2021"],"award-info":[{"award-number":["MO002D-2021"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003093","name":"Ministry of Higher Education, Malaysia","doi-asserted-by":"publisher","award":["MO002D-2021"],"award-info":[{"award-number":["MO002D-2021"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00284-026-05020-y","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T18:17:15Z","timestamp":1782238635000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Manifestations and Immunological Impacts in Co-Infections and Sequential Infections of SARS-CoV-2 and Arboviruses"],"prefix":"10.1007","volume":"83","author":[{"given":"Jalviana","family":"Lansayan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim-Ling","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sazaly","family":"AbuBakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurhafiza","family":"Zainal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"5020_CR1","unstructured":"World Health Organisation (2025) WHO COVID-19 dashboard. https:\/\/data.who.int\/dashboards\/covid19\/cases?n=c. Accessed 30\/5\/2025, 2025"},{"key":"5020_CR2","first-page":"1","volume-title":"Dengue and Zika: Control and Antiviral Treatment Strategies","author":"PR Young","year":"2018","unstructured":"Young PR (2018) Arboviruses: A family on the move. In: Hilgenfeld R, Vasudevan SG (eds) Dengue and Zika: Control and Antiviral Treatment Strategies. Springer, Singapore, pp 1\u201310"},{"issue":"12","key":"5020_CR3","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.3390\/v14122645","volume":"14","author":"Y Du","year":"2022","unstructured":"Du Y, Wang C, Zhang Y (2022) Viral coinfections. Viruses 14(12):2645. https:\/\/doi.org\/10.3390\/v14122645","journal-title":"Viruses"},{"issue":"7","key":"5020_CR4","doi-asserted-by":"publisher","first-page":"e00658","DOI":"10.1128\/mbio.00658-24","volume":"15","author":"T Chin","year":"2024","unstructured":"Chin T, Foxman EF, Watkins TA, Lipsitch M (2024) Considerations for viral co-infection studies in human populations. mBio 15(7):e00658\u2013e00624. https:\/\/doi.org\/10.1128\/mbio.00658-24","journal-title":"mBio"},{"issue":"5","key":"5020_CR5","doi-asserted-by":"publisher","first-page":"e0155589","DOI":"10.1371\/journal.pone.0155589","volume":"11","author":"L Pinky","year":"2016","unstructured":"Pinky L, Dobrovolny HM (2016) Coinfections of the respiratory tract: Viral competition for resources. PLoS ONE 11(5):e0155589. https:\/\/doi.org\/10.1371\/journal.pone.0155589","journal-title":"PLoS ONE"},{"issue":"2","key":"5020_CR6","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3201\/eid2802.211727","volume":"28","author":"J Piret","year":"2022","unstructured":"Piret J, Boivin G (2022) Viral interference between respiratory viruses. Emerg Infect Dis 28(2):273\u2013281. https:\/\/doi.org\/10.3201\/eid2802.211727","journal-title":"Emerg Infect Dis"},{"key":"5020_CR7","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s42003-022-03207-0","volume":"5","author":"S Wang","year":"2022","unstructured":"Wang S, Wang J, Yu X et al (2022) Antibody-dependent enhancement (ADE) of SARS-CoV-2 pseudoviral infection requires Fc\u03b3RIIB and virus-antibody complex with bivalent interaction. Commun Biol 5:262. https:\/\/doi.org\/10.1038\/s42003-022-03207-0","journal-title":"Commun Biol"},{"issue":"5","key":"5020_CR8","doi-asserted-by":"publisher","first-page":"e29628","DOI":"10.1002\/jmv.29628","volume":"96","author":"S Thomas","year":"2024","unstructured":"Thomas S, Smatti MK, Alsulaiti H et al (2024) Antibody-dependent enhancement (ADE) of SARS\u2010CoV\u20102 in patients exposed to MERS\u2010CoV and SARS\u2010CoV\u20102 antigens. J Med Virol 96(5):e29628. https:\/\/doi.org\/10.1002\/jmv.29628","journal-title":"J Med Virol"},{"issue":"10","key":"5020_CR9","doi-asserted-by":"publisher","first-page":"e1004386","DOI":"10.1371\/journal.ppat.1004386","volume":"10","author":"KL Alwis Rd, Williams","year":"2014","unstructured":"Alwis Rd, Williams KL, Schmid MA et al (2014) Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera. PLoS Pathog 10(10):e1004386. https:\/\/doi.org\/10.1371\/journal.ppat.1004386","journal-title":"PLoS Pathog"},{"issue":"5","key":"5020_CR10","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/S1473-3099(20)30158-4","volume":"20","author":"G Yan","year":"2020","unstructured":"Yan G, Lee CK, Lam LTM et al (2020) Covert COVID-19 and false-positive dengue serology in Singapore. Lancet Infect Dis 20(5):536. https:\/\/doi.org\/10.1016\/S1473-3099(20)30158-4","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"5020_CR11","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3390\/cells10040821","volume":"10","author":"R Yadav","year":"2021","unstructured":"Yadav R, Chaudhary JK, Jain N et al (2021) Role of structural and non-structural proteins and therapeutic targets of SARS-CoV-2 for COVID-19. Cells 10(4):821. https:\/\/doi.org\/10.3390\/cells10040821","journal-title":"Cells"},{"issue":"1","key":"5020_CR12","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3390\/v13010109","volume":"13","author":"X Xia","year":"2021","unstructured":"Xia X (2021) Domains and functions of spike protein in SARS-CoV-2 in the context of vaccine design. Viruses 13(1):109. https:\/\/doi.org\/10.3390\/v13010109","journal-title":"Viruses"},{"issue":"3","key":"5020_CR13","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","volume":"19","author":"B Hu","year":"2020","unstructured":"Hu B, Guo H, Zhou P, Shi ZL (2020) Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol 19(3):141\u2013154. https:\/\/doi.org\/10.1038\/s41579-020-00459-7","journal-title":"Nat Rev Microbiol"},{"issue":"21","key":"5020_CR14","doi-asserted-by":"publisher","first-page":"11727","DOI":"10.1073\/pnas.2003138117","volume":"117","author":"J Shang","year":"2020","unstructured":"Shang J, Wan Y, Luo C et al (2020) Cell entry mechanisms of SARS-CoV-2. Proc Natl Acad Sci U S A 117(21):11727\u201311734. https:\/\/doi.org\/10.1073\/pnas.2003138117","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5020_CR15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.cytogfr.2025.10.008","volume":"86","author":"V Anang","year":"2025","unstructured":"Anang V, Kumar P, Pracha J et al (2025) SARS-CoV-2 innate immune recognition and implications for respiratory health. Cytokine Growth Factor Rev 86:167\u2013180. https:\/\/doi.org\/10.1016\/j.cytogfr.2025.10.008","journal-title":"Cytokine Growth Factor Rev"},{"key":"5020_CR16","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s00277-023-05234-1","volume":"102","author":"M Sayyadi","year":"2023","unstructured":"Sayyadi M, Hassani S, Shams M et al (2023) Status of major hemostatic components in the setting of COVID-19: the effect on endothelium, platelets, coagulation factors, fibrinolytic system, and complement. Ann Hematol 102:1307\u20131322. https:\/\/doi.org\/10.1007\/s00277-023-05234-1","journal-title":"Ann Hematol"},{"key":"5020_CR17","doi-asserted-by":"publisher","unstructured":"Machado MEA, Kimura E (2022) Coinfection and cross-reaction of dengue and COVID-19: a case series analysis. Rev Soc Bras Med Trop 55(e0243-2022). https:\/\/doi.org\/10.1590\/0037-8682-0243-2022","DOI":"10.1590\/0037-8682-0243-2022"},{"issue":"1675","key":"5020_CR18","doi-asserted-by":"publisher","first-page":"20140299","DOI":"10.1098\/rstb.2014.0299","volume":"370","author":"BM Althouse","year":"2015","unstructured":"Althouse BM, Hanley KA (2015) The tortoise or the hare? Impacts of within-host dynamics on transmission success of arthropod-borne viruses. Philos Trans R Soc Lond B Biol Sci 370(1675):20140299. https:\/\/doi.org\/10.1098\/rstb.2014.0299","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"5020_CR19","doi-asserted-by":"publisher","unstructured":"Virgillito C, Longo E, De Marco CM et al (2025) Cross-sectional entomological data reveals an increased risk of arboviral transmission in a year of record-breaking heat in Southern Europe. Commun Med (Lond) 5(1). https:\/\/doi.org\/10.1038\/s43856-025-00983-8","DOI":"10.1038\/s43856-025-00983-8"},{"issue":"2","key":"5020_CR20","doi-asserted-by":"publisher","first-page":"e0281612","DOI":"10.1371\/journal.pone.0281612","volume":"18","author":"M Troj\u00e1nek","year":"2023","unstructured":"Troj\u00e1nek M, Grebenyuk V, Man\u010f\u00e1kov\u00e1 Z et al (2023) Epidemiology of dengue, chikungunya and Zika virus infections in travellers: A 16-year retrospective descriptive study at a tertiary care centre in Prague, Czech Republic. PLoS ONE 18(2):e0281612. https:\/\/doi.org\/10.1371\/journal.pone.0281612","journal-title":"PLoS ONE"},{"issue":"5","key":"5020_CR21","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3390\/v11050471","volume":"11","author":"N Vasilakis","year":"2019","unstructured":"Vasilakis N, Tesh RB, Popov VL et al (2019) Exploiting the legacy of the arbovirus hunters. Viruses 11(5):471. https:\/\/doi.org\/10.3390\/v11050471","journal-title":"Viruses"},{"key":"5020_CR22","unstructured":"Mangat R, Louie T (2024) Arbovirus encephalitides. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK560866\/. Accessed 2024\/06\/24"},{"issue":"6","key":"5020_CR23","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41564-020-0714-0","volume":"5","author":"TC Pierson","year":"2020","unstructured":"Pierson TC, Diamond MS (2020) The continued threat of emerging flaviviruses. Nat Microbiol 5(6):796\u2013812. https:\/\/doi.org\/10.1038\/s41564-020-0714-0","journal-title":"Nat Microbiol"},{"key":"5020_CR24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.virol.2022.02.001","volume":"568","author":"MN Anwar","year":"2022","unstructured":"Anwar MN, Akhtar R, Abid M et al (2022) The interactions of flaviviruses with cellular receptors: Implications for virus entry. Virology 568:77\u201385. https:\/\/doi.org\/10.1016\/j.virol.2022.02.001","journal-title":"Virology"},{"issue":"11","key":"5020_CR25","doi-asserted-by":"publisher","first-page":"4939","DOI":"10.1007\/s00018-021-03834-6","volume":"78","author":"Y Ci","year":"2021","unstructured":"Ci Y, Shi L (2021) Compartmentalized replication organelle of flavivirus at the ER and the factors involved. Cell Mol Life Sci 78(11):4939\u20134954. https:\/\/doi.org\/10.1007\/s00018-021-03834-6","journal-title":"Cell Mol Life Sci"},{"issue":"8","key":"5020_CR26","doi-asserted-by":"publisher","first-page":"e12884","DOI":"10.1111\/cmi.12884","volume":"20","author":"TE Aktepe","year":"2018","unstructured":"Aktepe TE, Mackenzie JM (2018) Shaping the flavivirus replication complex: It is curvaceous! Cell Microbiol 20(8):e12884. https:\/\/doi.org\/10.1111\/cmi.12884","journal-title":"Cell Microbiol"},{"issue":"1","key":"5020_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s44298-024-00031-7","volume":"2","author":"M Verhaegen","year":"2024","unstructured":"Verhaegen M, Vermeire K (2024) The endoplasmic reticulum (ER): A crucial cellular hub in flavivirus infection and potential target site for antiviral interventions. npj Viruses 2(1):1\u201317. https:\/\/doi.org\/10.1038\/s44298-024-00031-7","journal-title":"npj Viruses"},{"key":"5020_CR28","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3389\/fimmu.2020.00334","volume":"11","author":"APS Rathore","year":"2020","unstructured":"Rathore APS, St. John AL (2020) Cross-reactive immunity among flaviviruses. Front Immunol 11:334. https:\/\/doi.org\/10.3389\/fimmu.2020.00334","journal-title":"Front Immunol"},{"issue":"6","key":"5020_CR29","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41579-022-00825-7","volume":"21","author":"AS Kim","year":"2023","unstructured":"Kim AS, Diamond MS (2023) A molecular understanding of alphavirus entry and antibody protection. Nat Rev Microbiol 21(6):396\u2013407. https:\/\/doi.org\/10.1038\/s41579-022-00825-7","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"5020_CR30","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/rmv.681","volume":"21","author":"SK Singh","year":"2011","unstructured":"Singh SK, Unni SK (2011) Chikungunya virus: Host pathogen interaction. Rev Med Virol 21(2):78\u201388. https:\/\/doi.org\/10.1002\/rmv.681","journal-title":"Rev Med Virol"},{"issue":"1","key":"5020_CR31","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1038\/s41467-021-23400-9","volume":"12","author":"HV Ribeiro-Filho","year":"2021","unstructured":"Ribeiro-Filho HV, Coimbra LD, Cassago A et al (2021) Cryo-EM structure of the mature and infective Mayaro virus at 4.4 \u00c5 resolution reveals features of arthritogenic alphaviruses. Nat Commun 12(1):3038. https:\/\/doi.org\/10.1038\/s41467-021-23400-9","journal-title":"Nat Commun"},{"issue":"1","key":"5020_CR32","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41467-023-44624-x","volume":"15","author":"H Ma","year":"2024","unstructured":"Ma H, Adams LJ, Raju S et al (2024) The low-density lipoprotein receptor promotes infection of multiple encephalitic alphaviruses. Nat Commun 15(1):246. https:\/\/doi.org\/10.1038\/s41467-023-44624-x","journal-title":"Nat Commun"},{"issue":"1","key":"5020_CR33","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3390\/v12010081","volume":"12","author":"A Ahmed","year":"2020","unstructured":"Ahmed A, Dietrich I, LaBeaud AD et al (2020) Risks and challenges of arboviral diseases in Sudan: The urgent need for actions. Viruses 12(1):81. https:\/\/doi.org\/10.3390\/v12010081","journal-title":"Viruses"},{"key":"5020_CR34","doi-asserted-by":"publisher","unstructured":"Raju S, Adams LJ, Diamond MS (2024) The many ways in which alphaviruses bind to cells. Trends Immunol 45(2). https:\/\/doi.org\/10.1016\/j.it.2023.11.006","DOI":"10.1016\/j.it.2023.11.006"},{"key":"5020_CR35","doi-asserted-by":"publisher","first-page":"102313","DOI":"10.1016\/j.amsu.2021.102313","volume":"65","author":"S Taouihar","year":"2021","unstructured":"Taouihar S, Bouabdallaoui A, Aabdi M et al (2021) ST elevation revealing acute myocarditis with SARS-CoV-2 infection: Case report. Ann Med Surg (Lond) 65:102313. https:\/\/doi.org\/10.1016\/j.amsu.2021.102313","journal-title":"Ann Med Surg (Lond)"},{"issue":"T3","key":"5020_CR36","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3889\/oamjms.2021.6346","volume":"9","author":"MFG Siregar","year":"2021","unstructured":"Siregar MFG, Siregar EKH (2021) The effect of Coronavirus Disease 2019 on reproduction system and fertility. Open Access Maced J Med Sci 9(T3):362\u2013368. https:\/\/doi.org\/10.3889\/oamjms.2021.6346","journal-title":"Open Access Maced J Med Sci"},{"key":"5020_CR37","doi-asserted-by":"publisher","unstructured":"Kalita P, Dey B, Mishra J et al (2022) Immunoglobulin A nephropathy in a SARS-CoV-2-positive patient with coexistent metabolic syndrome. Cureus 14. https:\/\/doi.org\/10.7759\/cureus.28719","DOI":"10.7759\/cureus.28719"},{"issue":"7","key":"5020_CR38","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1080\/00207454.2021.1973000","volume":"13","author":"ZH Ousseiran","year":"2021","unstructured":"Ousseiran ZH, Fares Y, Chamoun WT (2021) Neurological manifestations of COVID-19: A systematic review and detailed comprehension. Int J Neurosci 13(7):754\u2013769. https:\/\/doi.org\/10.1080\/00207454.2021.1973000","journal-title":"Int J Neurosci"},{"issue":"7","key":"5020_CR39","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/jmv.25915","volume":"92","author":"A Paniz-Mondolfi","year":"2020","unstructured":"Paniz-Mondolfi A, Bryce C, Grimes Z et al (2020) Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). J Med Virol 92(7):699\u2013702. https:\/\/doi.org\/10.1002\/jmv.25915","journal-title":"J Med Virol"},{"key":"5020_CR40","doi-asserted-by":"publisher","unstructured":"Muzellina VN, Abdullah M, Kurniawan J, Rizka A (2023) Relationship between anal swab PCR for SARS-CoV-2 with gastrointestinal clinical manifestations and severity of COVID-19 infection in Indonesia. F1000Res 12:358. https:\/\/doi.org\/10.12688\/f1000research.128821.2","DOI":"10.12688\/f1000research.128821.2"},{"issue":"1","key":"5020_CR41","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3121\/cmr.2023.1598","volume":"21","author":"R Danarti","year":"2023","unstructured":"Danarti R, Limantara NV, Rini DLU et al (2023) Cutaneous manifestation in COVID-19: A lesson over 2 years into the pandemic. Clin Med Res 21(1):36\u201345. https:\/\/doi.org\/10.3121\/cmr.2023.1598","journal-title":"Clin Med Res"},{"issue":"10","key":"5020_CR42","doi-asserted-by":"publisher","first-page":"3549","DOI":"10.1007\/s00415-021-10450-8","volume":"268","author":"VR Ostovan","year":"2021","unstructured":"Ostovan VR, Foroughi R, Rostami M et al (2021) Cerebral venous sinus thrombosis associated with COVID-19: A case series and literature review. J Neurol 268(10):3549\u20133560. https:\/\/doi.org\/10.1007\/s00415-021-10450-8","journal-title":"J Neurol"},{"key":"5020_CR43","unstructured":"Schaefer TJ, Panda PK, Wolford RW (2024) Dengue fever. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28613483. Accessed 2024\/11\/10"},{"key":"5020_CR44","first-page":"147","volume-title":"Epidemiology, burden of disease and transmission. Dengue: guidelines for diagnosis, treatment, prevention and control - New edition","author":"MB Nathan","year":"2009","unstructured":"Nathan MB, Dayal-Drager R, Guzman M (2009) Epidemiology, burden of disease and transmission. Dengue: guidelines for diagnosis, treatment, prevention and control - New edition. World Health Organisation, Geneva, p 147"},{"key":"5020_CR45","doi-asserted-by":"publisher","unstructured":"Halani S, Tombindo PE, O\u2019Reilly R et al (2021) Clinical manifestations and health outcomes associated with Zika virus infections in adults: A systematic review. PLoS Negl Trop Dis 15(7). https:\/\/doi.org\/10.1371\/journal.pntd.0009516","DOI":"10.1371\/journal.pntd.0009516"},{"issue":"1","key":"5020_CR46","doi-asserted-by":"publisher","first-page":"e1002203","DOI":"10.1371\/journal.pmed.1002203","volume":"14","author":"F Krauer","year":"2017","unstructured":"Krauer F, Riesen M, Reveiz L et al (2017) Zika virus infection as a cause of congenital brain abnormalities and Guillain\u2013Barr\u00e9 syndrome: Systematic review. PLoS Med 14(1):e1002203. https:\/\/doi.org\/10.1371\/journal.pmed.1002203","journal-title":"PLoS Med"},{"issue":"4","key":"5020_CR47","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s11926-021-00987-y","volume":"23","author":"K Suchowiecki","year":"2021","unstructured":"Suchowiecki K, Reid SP, Simon GL et al (2021) Persistent joint pain following arthropod virus infections. Curr Rheumatol Rep 23(4):26. https:\/\/doi.org\/10.1007\/s11926-021-00987-y","journal-title":"Curr Rheumatol Rep"},{"issue":"5","key":"5020_CR48","doi-asserted-by":"publisher","first-page":"899","DOI":"10.3390\/microorganisms9050899","volume":"9","author":"A Torres-Ruesta","year":"2021","unstructured":"Torres-Ruesta A, Chee RS-L, Ng LFP (2021) Insights into antibody-mediated alphavirus immunity and vaccine development landscape. Microorganisms 9(5):899. https:\/\/doi.org\/10.3390\/microorganisms9050899","journal-title":"Microorganisms"},{"issue":"3","key":"5020_CR49","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3390\/v11030290","volume":"11","author":"H Mostafavi","year":"2019","unstructured":"Mostafavi H, Abeyratne E, Zaid A, Taylor A (2019) Arthritogenic alphavirus-induced immunopathology and targeting host inflammation as a therapeutic strategy for alphaviral disease. Viruses 11(3):290. https:\/\/doi.org\/10.3390\/v11030290","journal-title":"Viruses"},{"key":"5020_CR50","doi-asserted-by":"publisher","unstructured":"Flisiak R, Jaroszewicz J, Kozielewicz D et al (2025) Management of SARS-CoV-2 Infection-Clinical Practice Guidelines of the Polish Association of Epidemiologists and Infectiologists, for 2025. J Clin Med 14(7). https:\/\/doi.org\/10.3390\/jcm14072305","DOI":"10.3390\/jcm14072305"},{"key":"5020_CR51","doi-asserted-by":"publisher","unstructured":"Aiello TF, Garc\u00eda-Vidal C, Soriano A (2022) Antiviral drugs against SARS-CoV-2. Rev Esp Quimioter 35(Suppl 3). https:\/\/doi.org\/10.37201\/req\/s03.03.2022","DOI":"10.37201\/req\/s03.03.2022"},{"key":"5020_CR52","unstructured":"World Health Organisation (2025) WHO guidelines for clinical management of arboviral diseases: dengue, chikungunya, Zika and yellow fever. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK616306\/. Accessed 16\/04\/2026, 2026"},{"key":"5020_CR53","doi-asserted-by":"publisher","first-page":"872627","DOI":"10.3389\/fmed.2022.872627","volume":"9","author":"CNBS Prapty","year":"2022","unstructured":"Prapty CNBS, Ahmed N, Araf Y et al (2022) Coinfection of COVID-19 and dengue: A case report. Front Med 9:872627","journal-title":"Front Med"},{"issue":"1","key":"5020_CR54","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40794-022-00169-3","volume":"8","author":"T Acosta-P\u00e9rez","year":"2022","unstructured":"Acosta-P\u00e9rez T, Rodr\u00edguez-Y\u00e1nez T, Almanza-Hurtado A et al (2022) Dynamics of dengue and SARS-COV-2 co-infection in an endemic area of Colombia. Trop Dis Travel Med Vaccines 8(1):12. https:\/\/doi.org\/10.1186\/s40794-022-00169-3","journal-title":"Trop Dis Travel Med Vaccines"},{"key":"5020_CR55","doi-asserted-by":"publisher","unstructured":"D\u00fclger AC, Yakari\u015fik M, Uzun YE, \u015eahin AM (2020) Treatment of Crimean-Congo Haemorrhagic Fever by favipiravir in a patient with novel coronavirus co-Infection. Eur J Case Rep Intern Med 7(12). https:\/\/doi.org\/10.12890\/2020_002042","DOI":"10.12890\/2020_002042"},{"key":"5020_CR56","doi-asserted-by":"publisher","unstructured":"Hawman DW, Haddock E, Meade-White K et al (2020) Efficacy of favipiravir (T-705) against Crimean-Congo hemorrhagic fever virus infection in cynomolgus macaques. Antiviral Res 181. https:\/\/doi.org\/10.1016\/j.antiviral.2020.104858","DOI":"10.1016\/j.antiviral.2020.104858"},{"key":"5020_CR57","doi-asserted-by":"publisher","unstructured":"Marlin R, Desjardins D, Contreras V et al (2022) Antiviral efficacy of favipiravir against Zika and SARS-CoV-2 viruses in non-human primates. Nat Commun 13(1). https:\/\/doi.org\/10.1038\/s41467-022-32565-w","DOI":"10.1038\/s41467-022-32565-w"},{"issue":"43","key":"5020_CR58","doi-asserted-by":"publisher","first-page":"26955","DOI":"10.1073\/pnas.2014441117","volume":"117","author":"SJF Kaptein","year":"2020","unstructured":"Kaptein SJF, Jacobs S, Langendries L et al (2020) Favipiravir at high doses has potent antiviral activity in SARS-CoV-2\u2009\u2013\u2009infected hamsters, whereas hydroxychloroquine lacks activity. Proc Natl Acad Sci U S A 117(43):26955\u201326965. https:\/\/doi.org\/10.1073\/pnas.2014441117","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5020_CR59","doi-asserted-by":"publisher","unstructured":"Driouich J-S, Cochin M, Lingas G et al (2021) Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model. Nat Commun 12(1). https:\/\/doi.org\/10.1038\/s41467-021-21992-w","DOI":"10.1038\/s41467-021-21992-w"},{"key":"5020_CR60","doi-asserted-by":"publisher","unstructured":"Bahar MA, Kusuma IY, Visnyovszki \u00c1 et al (2024) Favipiravir does not improve viral clearance in mild to moderate COVID-19 \u2013 A systematic review and meta-analysis of randomized controlled trials. Heliyon 10(9). https:\/\/doi.org\/10.1016\/j.heliyon.2024.e29808","DOI":"10.1016\/j.heliyon.2024.e29808"},{"key":"5020_CR61","doi-asserted-by":"publisher","unstructured":"Luvira V, Schilling WHK, Jittamala P et al (2024) Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial. BMC Infect Dis 24(1). https:\/\/doi.org\/10.1186\/s12879-023-08835-3","DOI":"10.1186\/s12879-023-08835-3"},{"issue":"9","key":"5020_CR62","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1007\/s11010-023-04848-3","volume":"479","author":"A Das","year":"2023","unstructured":"Das A, Pathak S, Premkumar M et al (2023) A brief overview of SARS-CoV-2 infection and its management strategies: a recent update. Mol Cell Biochem 479(9):2195\u20132215. https:\/\/doi.org\/10.1007\/s11010-023-04848-3","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"5020_CR63","doi-asserted-by":"publisher","first-page":"p149","DOI":"10.1016\/j.cell.2020.11.025","volume":"184","author":"R Karki","year":"2020","unstructured":"Karki R, Sharma BR, Tuladhar S et al (2020) Synergism of TNF-\u03b1 and IFN-\u03b3 triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes. Cell 184(1):p149\u2013168e117. https:\/\/doi.org\/10.1016\/j.cell.2020.11.025","journal-title":"Cell"},{"key":"5020_CR64","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.imlet.2023.06.008","volume":"260","author":"AY Majeed","year":"2023","unstructured":"Majeed AY, Zulkafli NES, Ad\u2019hiah AH (2023) Serum profiles of pro-inflammatory and anti-inflammatory cytokines in non-hospitalized patients with mild\/moderate COVID-19 infection. Immunol Lett 260:24\u201334. https:\/\/doi.org\/10.1016\/j.imlet.2023.06.008","journal-title":"Immunol Lett"},{"issue":"1","key":"5020_CR65","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12929-018-0482-9","volume":"25","author":"S-W Wan","year":"2018","unstructured":"Wan S-W, Wu-Hsieh BA, Lin Y-S et al (2018) The monocyte-macrophage-mast cell axis in dengue pathogenesis. J Biomed Sci 25(1):77. https:\/\/doi.org\/10.1186\/s12929-018-0482-9","journal-title":"J Biomed Sci"},{"key":"5020_CR66","doi-asserted-by":"publisher","first-page":"101522","DOI":"10.1016\/j.smim.2021.101522","volume":"55","author":"I-E Galani","year":"2021","unstructured":"Galani I-E, Andreakos E (2021) Impaired innate antiviral defenses in COVID-19: Causes, consequences and therapeutic opportunities. Semin Immunol 55:101522. https:\/\/doi.org\/10.1016\/j.smim.2021.101522","journal-title":"Semin Immunol"},{"issue":"21","key":"5020_CR67","doi-asserted-by":"publisher","first-page":"11624","DOI":"10.3390\/ijms252111624","volume":"25","author":"AH Garc\u00eda","year":"2024","unstructured":"Garc\u00eda AH, De Sanctis JB (2024) Exploring the contrasts and similarities of dengue and SARS-CoV-2 infections during the COVID-19 era. Int J Mol Sci 25(21):11624. https:\/\/doi.org\/10.3390\/ijms252111624","journal-title":"Int J Mol Sci"},{"key":"5020_CR68","doi-asserted-by":"publisher","first-page":"1429309","DOI":"10.3389\/fcimb.2024.1429309","volume":"14","author":"TMIL Santos","year":"2024","unstructured":"Santos TMIL, Versiani AF, Campos GRF et al (2024) Dengue and SARS-CoV-2 co-circulation and overlapping infections in hospitalized patients. Front Cell Infect Microbiol 14:1429309. https:\/\/doi.org\/10.3389\/fcimb.2024.1429309","journal-title":"Front Cell Infect Microbiol"},{"issue":"11","key":"5020_CR69","doi-asserted-by":"publisher","first-page":"e31877","DOI":"10.7759\/cureus.31877","volume":"14","author":"D Alla","year":"2022","unstructured":"Alla D, Alla SSM, Vempati R et al (2022) Dengue & COVID-19: A comparison and the challenges at hand. Cureus 14(11):e31877. https:\/\/doi.org\/10.7759\/cureus.31877","journal-title":"Cureus"},{"issue":"7914","key":"5020_CR70","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41586-022-04702-4","volume":"606","author":"C Junqueira","year":"2022","unstructured":"Junqueira C, Crespo \u00c2, Ranjbar S et al (2022) Fc\u03b3R-mediated SARS-CoV-2 infection of monocytes activates inflammation. Nature 606(7914):576\u2013584. https:\/\/doi.org\/10.1038\/s41586-022-04702-4","journal-title":"Nature"},{"issue":"10","key":"5020_CR71","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.3390\/v14102194","volume":"14","author":"RS Peinado","year":"2022","unstructured":"Peinado RS, Eberle RJ, Arni RK, Coronado MA (2022) A review of omics studies on arboviruses: alphavirus, orthobunyavirus and phlebovirus. Viruses 14(10):2194. https:\/\/doi.org\/10.3390\/v14102194","journal-title":"Viruses"},{"issue":"Suppl 2","key":"5020_CR72","doi-asserted-by":"publisher","first-page":"S227","DOI":"10.33549\/physiolres.934757","volume":"70","author":"M Barnova","year":"2021","unstructured":"Barnova M, Bobcakova A, Urdova V et al (2021) Inhibitory immune checkpoint molecules and exhaustion of T cells in COVID-19. Physiol Res 70(Suppl 2):S227\u2013S247. https:\/\/doi.org\/10.33549\/physiolres.934757","journal-title":"Physiol Res"},{"issue":"9","key":"5020_CR73","doi-asserted-by":"publisher","first-page":"000259","DOI":"10.1099\/acmi.0.000259","volume":"3","author":"ME Soria","year":"2021","unstructured":"Soria ME, Cort\u00f3n M, Mart\u00ednez-Gonz\u00e1lez B et al (2021) High SARS-CoV-2 viral load is associated with a worse clinical outcome of COVID-19 disease. Access Microbiol 3(9):000259. https:\/\/doi.org\/10.1099\/acmi.0.000259","journal-title":"Access Microbiol"},{"key":"5020_CR74","doi-asserted-by":"publisher","unstructured":"Balz K, Trassl L, H\u00e4rtel V et al (2020) Virus-induced T cell-mediated heterologous immunity and vaccine development. Front Immunol 11. https:\/\/doi.org\/10.3389\/fimmu.2020.00513","DOI":"10.3389\/fimmu.2020.00513"},{"issue":"3","key":"5020_CR75","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1189\/jlb.0713386","volume":"95","author":"S Sharma","year":"2014","unstructured":"Sharma S, Thomas PG (2014) The two faces of heterologous immunity: protection or immunopathology. J Leukoc Biol 95(3):405\u2013416. https:\/\/doi.org\/10.1189\/jlb.0713386","journal-title":"J Leukoc Biol"},{"issue":"5","key":"5020_CR76","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1007\/s10875-021-00997-6","volume":"41","author":"J Hicks","year":"2021","unstructured":"Hicks J, Klumpp-Thomas C, Kalish H et al (2021) Serologic cross-reactivity of SARS-CoV-2 with endemic and seasonal betacoronaviruses. J Clin Immunol 41(5):906\u2013913. https:\/\/doi.org\/10.1007\/s10875-021-00997-6","journal-title":"J Clin Immunol"},{"key":"5020_CR77","doi-asserted-by":"publisher","unstructured":"Lee Richard SH, Cheng Samuel MS, Zhao J et al (2024) Cross-reactive antibody responses to coronaviruses elicited by SARS\u2010CoV\u20102 infection or vaccination. nfluenza Other Respir Viruses 18(5). https:\/\/doi.org\/10.1111\/irv.13309","DOI":"10.1111\/irv.13309"},{"issue":"1","key":"5020_CR78","doi-asserted-by":"publisher","first-page":"6496","DOI":"10.1038\/s41598-022-10230-y","volume":"12","author":"ES Geanes","year":"2022","unstructured":"Geanes ES, LeMaster C, Fraley ER et al (2022) Cross-reactive antibodies elicited to conserved epitopes on SARS-CoV-2 spike protein after infection and vaccination. Sci Rep 12(1):6496. https:\/\/doi.org\/10.1038\/s41598-022-10230-y","journal-title":"Sci Rep"},{"key":"5020_CR79","doi-asserted-by":"publisher","first-page":"1182504","DOI":"10.3389\/fimmu.2023.1182504","volume":"14","author":"T Westphal","year":"2023","unstructured":"Westphal T, Mader M, Karsten H et al (2023) Evidence for broad cross-reactivity of the SARS-CoV-2 NSP12-directed CD4\u2009+\u2009T-cell response with pre-primed responses directed against common cold coronaviruses. Front Immunol 14:1182504. https:\/\/doi.org\/10.3389\/fimmu.2023.1182504","journal-title":"Front Immunol"},{"issue":"6","key":"5020_CR80","doi-asserted-by":"publisher","first-page":"101088","DOI":"10.1016\/j.xcrm.2023.101088","volume":"4","author":"A Tarke","year":"2023","unstructured":"Tarke A, Zhang Y, Methot N et al (2023) Targets and cross-reactivity of human T cell recognition of common cold coronaviruses. Cell Rep Med 4(6):101088. https:\/\/doi.org\/10.1016\/j.xcrm.2023.101088","journal-title":"Cell Rep Med"},{"key":"5020_CR81","doi-asserted-by":"publisher","unstructured":"Zhu Y, Yu D, Han Y et al (2020) Cross-reactive neutralization of SARS-CoV-2 by serum antibodies from recovered SARS patients and immunized animals. Sci Adv 6(45). https:\/\/doi.org\/10.1126\/sciadv.abc9999","DOI":"10.1126\/sciadv.abc9999"},{"key":"5020_CR82","doi-asserted-by":"publisher","unstructured":"McNaughton AL, Paton RS, Edmans M et al (2022) Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses. JCI Insight 7(13). https:\/\/doi.org\/10.1172\/jci.insight.156372","DOI":"10.1172\/jci.insight.156372"},{"key":"5020_CR83","doi-asserted-by":"publisher","unstructured":"Guo L, Wang Y, Kang L et al (2021) Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study. Emerg Microbes Infect 10(1). https:\/\/doi.org\/10.1080\/22221751.2021.1905488","DOI":"10.1080\/22221751.2021.1905488"},{"key":"5020_CR84","doi-asserted-by":"publisher","unstructured":"Imai K, Matsuoka M, Tabata S et al (2021) Cross-reactive humoral immune responses against seasonal human coronaviruses in COVID-19 patients with different disease severities. Int J Infect Dis 111. https:\/\/doi.org\/10.1016\/j.ijid.2021.08.026","DOI":"10.1016\/j.ijid.2021.08.026"},{"issue":"5","key":"5020_CR85","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s41577-022-00809-x","volume":"23","author":"SM Murray","year":"2022","unstructured":"Murray SM, Ansari AM, Frater J et al (2022) The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses. Nat Rev Immunol 23(5):304\u2013316. https:\/\/doi.org\/10.1038\/s41577-022-00809-x","journal-title":"Nat Rev Immunol"},{"key":"5020_CR86","doi-asserted-by":"publisher","unstructured":"Chan KR, Ismail AA, Thergarajan G et al (2022) Serological cross-reactivity among common flaviviruses. Front Cell Infect Microbiol 12. https:\/\/doi.org\/10.3389\/fcimb.2022.975398","DOI":"10.3389\/fcimb.2022.975398"},{"key":"5020_CR87","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ijid.2023.01.033","volume":"129","author":"BB Salgado","year":"2023","unstructured":"Salgado BB, Mau\u00e9s FCJ, Jord\u00e3o M et al (2023) Antibody cross-reactivity and evidence of susceptibility to emerging flaviviruses in the dengue-endemic Brazilian Amazon. Int J Infect Dis 129:142\u2013151. https:\/\/doi.org\/10.1016\/j.ijid.2023.01.033","journal-title":"Int J Infect Dis"},{"issue":"1","key":"5020_CR88","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12929-023-00938-y","volume":"30","author":"L-C Yen","year":"2023","unstructured":"Yen L-C, Chen H-W, Ho C-L et al (2023) Neutralizing antibodies targeting a novel epitope on envelope protein exhibited broad protection against flavivirus without risk of disease enhancement. J Biomed Sci 30(1):41. https:\/\/doi.org\/10.1186\/s12929-023-00938-y","journal-title":"J Biomed Sci"},{"key":"5020_CR89","doi-asserted-by":"publisher","unstructured":"Tricou V, Yu D, Reynales H et al (2024) Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4\u00b75-year results from a phase 3, randomised, double-blind, placebo-controlled trial. Lancet Glob Health 12(2). https:\/\/doi.org\/10.1016\/S2214-109X(23)00522-3","DOI":"10.1016\/S2214-109X(23)00522-3"},{"key":"5020_CR90","doi-asserted-by":"publisher","unstructured":"Churrotin S, Amarullah IH, Fitria AL et al (2024) Cross-reactivity between dengue virus and SARS-CoV-2 antibodies: Confirmation study using specimens from dengue-infected patients before the COVID-19 pandemic. Heliyon 10(21). https:\/\/doi.org\/10.1016\/j.heliyon.2024.e39099","DOI":"10.1016\/j.heliyon.2024.e39099"},{"issue":"6","key":"5020_CR91","doi-asserted-by":"publisher","first-page":"e0263922","DOI":"10.1128\/spectrum.02639-22","volume":"10","author":"T Hunsawong","year":"2022","unstructured":"Hunsawong T, Buddhari D, Rungrojcharoenkit K et al (2022) Anti-arbovirus antibodies cross-react with severe acute respiratory syndrome coronavirus 2. Microbiol Spectr 10(6):e0263922. https:\/\/doi.org\/10.1128\/spectrum.02639-22","journal-title":"Microbiol Spectr"},{"key":"5020_CR92","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ijid.2022.07.013","volume":"122","author":"H Nath","year":"2022","unstructured":"Nath H, Mallick A, Roy S et al (2022) COVID-19 serum can be cross-reactive and neutralizing against the dengue virus, as observed by the dengue virus neutralization test. Int J Infect Dis 122:576\u2013584. https:\/\/doi.org\/10.1016\/j.ijid.2022.07.013","journal-title":"Int J Infect Dis"},{"key":"5020_CR93","doi-asserted-by":"publisher","unstructured":"Cheng YL, Chao CH, Lai YC et al (2022) Antibodies against the SARS-CoV-2 S1-RBD cross-react with dengue virus and hinder dengue pathogenesis. Front Immunol 13:941923. https:\/\/doi.org\/10.3389\/fimmu.2022.941923","DOI":"10.3389\/fimmu.2022.941923"},{"issue":"3","key":"5020_CR94","doi-asserted-by":"publisher","first-page":"105464","DOI":"10.1016\/j.micinf.2024.105464","volume":"27","author":"JM Coish","year":"2024","unstructured":"Coish JM, MacNeil LA, MacNeil AJ (2024) The SARS-CoV-2 antibody-dependent enhancement fa\u00e7ade. Microbes Infect 27(3):105464. https:\/\/doi.org\/10.1016\/j.micinf.2024.105464","journal-title":"Microbes Infect"},{"issue":"1","key":"5020_CR95","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/imr.13393","volume":"328","author":"JE Edgar","year":"2024","unstructured":"Edgar JE, Bournazos S (2024) Fc-Fc\u03b3R interactions during infections: From neutralizing antibodies to antibody\u2010dependent enhancement. Immunol Rev 328(1):221\u2013242. https:\/\/doi.org\/10.1111\/imr.13393","journal-title":"Immunol Rev"},{"issue":"1","key":"5020_CR96","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40794-024-00231-2","volume":"10","author":"DG Aynekulu Mersha","year":"2024","unstructured":"Aynekulu Mersha DG, van der Sterren I, van Leeuwen LPM et al (2024) The role of antibody-dependent enhancement in dengue vaccination. Trop Dis Travel Med Vaccines 10(1):22. https:\/\/doi.org\/10.1186\/s40794-024-00231-2","journal-title":"Trop Dis Travel Med Vaccines"},{"issue":"6546","key":"5020_CR97","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1126\/science.abc7303","volume":"372","author":"S Bournazos","year":"2021","unstructured":"Bournazos S, Vo HTM, Duong V et al (2021) Antibody fucosylation predicts disease severity in secondary dengue infection. Science 372(6546):1102. https:\/\/doi.org\/10.1126\/science.abc7303","journal-title":"Science"},{"key":"5020_CR98","doi-asserted-by":"publisher","unstructured":"Wang TT, Sewatanon J, Memoli MJ et al (2017) IgG antibodies to dengue enhanced for Fc\u03b3RIIIA binding determine disease severity. Science 355(6323). https:\/\/doi.org\/10.1126\/science.aai8128","DOI":"10.1126\/science.aai8128"},{"key":"5020_CR99","doi-asserted-by":"publisher","unstructured":"Boonnak K, Slike BM, Donofrio GC, Marovich MA (2013) Human Fc\u03b3RII cytoplasmic domains differentially influence antibody-mediated dengue virus infection. J Immunol 190(11). https:\/\/doi.org\/10.4049\/jimmunol.1203052","DOI":"10.4049\/jimmunol.1203052"},{"key":"5020_CR100","doi-asserted-by":"publisher","unstructured":"Chelluboina S, Kshirsagar D, Panzade G et al (2025) Evaluation of methods for the measurement of antibody-dependent enhancement of dengue virus infection using different Fc\u03b3RIIa expressing cell lines. PLoS ONE 20(8). https:\/\/doi.org\/10.1371\/journal.pone.0331320","DOI":"10.1371\/journal.pone.0331320"},{"key":"5020_CR101","doi-asserted-by":"publisher","unstructured":"Coillie JV, Pongracz T, \u0160u\u0161ti\u0107 T et al (2023) Comparative analysis of spike-specific IgG Fc glycoprofiles elicited by adenoviral, mRNA, and protein-based SARS-CoV-2 vaccines. iScience 26(9). https:\/\/doi.org\/10.1016\/j.isci.2023.107619","DOI":"10.1016\/j.isci.2023.107619"},{"key":"5020_CR102","doi-asserted-by":"publisher","unstructured":"Chakraborty S, Gonzalez JC, Sievers BL et al (2022) Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity. Sci Transl Med 14(635). https:\/\/doi.org\/10.1126\/scitranslmed.abm7853","DOI":"10.1126\/scitranslmed.abm7853"},{"key":"5020_CR103","doi-asserted-by":"publisher","unstructured":"Kuzmina NA, Periasamy S, Kedarinath K et al (2026) SARS-CoV-2 antibody\u2013dependent enhancement of infection depends on antibody binding to both ACE2 and Fc receptors. JCI Insight 11(4). https:\/\/doi.org\/10.1172\/jci.insight.197773","DOI":"10.1172\/jci.insight.197773"},{"key":"5020_CR104","doi-asserted-by":"publisher","unstructured":"Thomas S, Smatti MK, AlKhatib HAM et al (2025) Antibody-dependent enhancement of SARS-CoV-2, the impact of variants and vaccination. Hum Vaccin Immunother 21(1). https:\/\/doi.org\/10.1080\/21645515.2025.2505356","DOI":"10.1080\/21645515.2025.2505356"},{"key":"5020_CR105","doi-asserted-by":"publisher","unstructured":"Jakhar K, Sonar S, Singh G et al (2026) Frontiers | SARS-CoV-2 spike antibodies cross-react with dengue virus and enhance infection in vitro and in vivo. Front Immunol 16. https:\/\/doi.org\/10.3389\/fimmu.2025.1724625","DOI":"10.3389\/fimmu.2025.1724625"},{"issue":"12","key":"5020_CR106","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.3390\/v11121136","volume":"11","author":"F Begum","year":"2019","unstructured":"Begum F, Das S, Mukherjee D et al (2019) Insight into the tropism of dengue virus in humans. Viruses 11(12):1136. https:\/\/doi.org\/10.3390\/v11121136","journal-title":"Viruses"},{"issue":"Supplement2","key":"5020_CR107","doi-asserted-by":"publisher","first-page":"S103","DOI":"10.1093\/jpids\/piae027","volume":"13","author":"A Noor","year":"2024","unstructured":"Noor A, Krilov LR (2024) A historical perspective on respiratory syncytial virus prevention: A journey spanning over half a century from the setback of an inactive vaccine candidate to the success of passive immunization strategy. J Pediatr Infect Dis Soc 13(Supplement2):S103\u2013S109. https:\/\/doi.org\/10.1093\/jpids\/piae027","journal-title":"J Pediatr Infect Dis Soc"},{"key":"5020_CR108","doi-asserted-by":"publisher","unstructured":"Kokubo K, Onodera A, Kiuchi M et al (2022) Conventional and pathogenic Th2 cells in inflammation, tissue repair, and fibrosis. Front Immunol 13(945063). https:\/\/doi.org\/10.3389\/fimmu.2022.945063","DOI":"10.3389\/fimmu.2022.945063"},{"key":"5020_CR109","doi-asserted-by":"publisher","first-page":"882972","DOI":"10.3389\/fimmu.2022.882972","volume":"13","author":"C Gartlan","year":"2022","unstructured":"Gartlan C, Tipton T, Salguero FJ et al (2022) Vaccine-associated enhanced disease and pathogenic human coronaviruses. Front Immunol 13:882972. https:\/\/doi.org\/10.3389\/fimmu.2022.882972","journal-title":"Front Immunol"},{"issue":"1","key":"5020_CR110","doi-asserted-by":"publisher","first-page":"e29408","DOI":"10.1002\/jmv.29408","volume":"96","author":"T Zhang","year":"2024","unstructured":"Zhang T, Magazine N, McGee MC et al (2024) Th2 and Th17-associated immunopathology following SARS-CoV-2 breakthrough infection in spike-vaccinated ACE2-humanized mice. J Med Virol 96(1):e29408. https:\/\/doi.org\/10.1002\/jmv.29408","journal-title":"J Med Virol"},{"issue":"10","key":"5020_CR111","doi-asserted-by":"publisher","first-page":"e0141164","DOI":"10.1371\/journal.pone.0141164","volume":"10","author":"I Poizot-Martin","year":"2015","unstructured":"Poizot-Martin I, Naqvi A, Obry-Roguet V et al (2015) Potential for drug-drug interactions between antiretrovirals and HCV direct acting antivirals in a large cohort of HIV\/HCV coinfected patients. PLoS ONE 10(10):e0141164. https:\/\/doi.org\/10.1371\/journal.pone.0141164","journal-title":"PLoS ONE"},{"issue":"02","key":"5020_CR112","doi-asserted-by":"publisher","first-page":"259","DOI":"10.37421\/2684-4559.2024.8.259","volume":"8","author":"R Pana","year":"2024","unstructured":"Pana R (2024) Comparative effectiveness of monoclonal antibodies in the management of viral infections. Clin Infect Dis 8(02):259. https:\/\/doi.org\/10.37421\/2684-4559.2024.8.259","journal-title":"Clin Infect Dis"},{"key":"5020_CR113","doi-asserted-by":"publisher","first-page":"100944","DOI":"10.1016\/j.nmni.2021.100944","volume":"44","author":"ZM Holliday","year":"2021","unstructured":"Holliday ZM, Alnijoumi MM, Reed MA et al (2021) Neutrophils and secondary infections in COVID-19 induced acute respiratory distress syndrome. New Microbes New Infect 44:100944. https:\/\/doi.org\/10.1016\/j.nmni.2021.100944","journal-title":"New Microbes New Infect"},{"key":"5020_CR114","doi-asserted-by":"publisher","first-page":"e20190246","DOI":"10.1590\/1806-3713\/e20190246","volume":"46","author":"E Marchiori","year":"2020","unstructured":"Marchiori E, Hochhegger B, Zanetti G (2020) Pulmonary manifestations of dengue. J Bras Pneumol 46:e20190246. https:\/\/doi.org\/10.1590\/1806-3713\/e20190246","journal-title":"J Bras Pneumol"},{"issue":"1","key":"5020_CR115","doi-asserted-by":"publisher","first-page":"e001578","DOI":"10.1136\/bmjpo-2022-001578","volume":"6","author":"N Preeprem","year":"2022","unstructured":"Preeprem N, Phumeetham S (2022) Paediatric dengue shock syndrome and acute respiratory failure: A single-centre retrospective study. BMJ Paediatr Open 6(1):e001578. https:\/\/doi.org\/10.1136\/bmjpo-2022-001578","journal-title":"BMJ Paediatr Open"},{"issue":"05","key":"5020_CR116","doi-asserted-by":"publisher","first-page":"001","DOI":"10.1055\/s-0044-1779504","volume":"82","author":"LPOZ Gomes","year":"2024","unstructured":"Gomes LPOZ, Martins CM, Pacheco EC et al (2024) Neurological and neuropsychiatric manifestations of post-COVID-19 condition in South America: A systematic review of the literature. Arq Neuropsiquiatr 82(05):001\u2013008. https:\/\/doi.org\/10.1055\/s-0044-1779504","journal-title":"Arq Neuropsiquiatr"},{"key":"5020_CR117","doi-asserted-by":"publisher","first-page":"205031212412298","DOI":"10.1177\/20503121241229847","volume":"12","author":"BS Srichawla","year":"2024","unstructured":"Srichawla BS, Manan MR, Kipkorir V et al (2024) Neuroinvasion of emerging and re-emerging arboviruses: A scoping review. SAGE Open Med 12:20503121241229847. https:\/\/doi.org\/10.1177\/20503121241229847","journal-title":"SAGE Open Med"},{"issue":"4","key":"5020_CR118","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3390\/microorganisms12040657","volume":"12","author":"S Zidovec-Lepej","year":"2024","unstructured":"Zidovec-Lepej S, Boduli\u0107 K, Bogdanic M et al (2024) Proinflammatory chemokine levels in cerebrospinal fluid of patients with neuroinvasive flavivirus infections. Microorganisms 12(4):657. https:\/\/doi.org\/10.3390\/microorganisms12040657","journal-title":"Microorganisms"},{"issue":"10","key":"5020_CR119","doi-asserted-by":"publisher","first-page":"e250535","DOI":"10.1136\/bcr-2022-250535","volume":"15","author":"D Masaad","year":"2022","unstructured":"Masaad D, Youssef S, Safadi MF, Agha MS (2022) MRI-negative myelitis associated with cerebral venous thrombosis after COVID-19 infection. BMJ Case Rep 15(10):e250535. https:\/\/doi.org\/10.1136\/bcr-2022-250535","journal-title":"BMJ Case Rep"},{"issue":"1","key":"5020_CR120","doi-asserted-by":"publisher","first-page":"ofy325","DOI":"10.1093\/ofid\/ofy325","volume":"6","author":"EA Van Dyne","year":"2019","unstructured":"Van Dyne EA, Neaterour P, Rivera A et al (2019) Incidence and outcome of severe and nonsevere thrombocytopenia associated with Zika virus infection\u2014Puerto Rico, 2016. Open Forum Infect Dis 6(1):ofy325. https:\/\/doi.org\/10.1093\/ofid\/ofy325","journal-title":"Open Forum Infect Dis"},{"issue":"01","key":"5020_CR121","doi-asserted-by":"publisher","first-page":"211","DOI":"10.4103\/ajns.AJNS_318_17","volume":"14","author":"R Kutty","year":"2022","unstructured":"Kutty R, Sreemathyamma S, Sivanandapanicker J et al (2022) Burden of dengue-related neurosurgical emergencies during an epidemic: A tertiary care experience. Asian J Neurosurg 14(01):211\u2013218. https:\/\/doi.org\/10.4103\/ajns.AJNS_318_17","journal-title":"Asian J Neurosurg"},{"key":"5020_CR122","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.trsl.2020.08.004","volume":"226","author":"S Villapol","year":"2020","unstructured":"Villapol S (2020) Gastrointestinal symptoms associated with COVID-19: Impact on the gut microbiome. Transl Res 226:57\u201369. https:\/\/doi.org\/10.1016\/j.trsl.2020.08.004","journal-title":"Transl Res"},{"issue":"1","key":"5020_CR123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41426-018-0163-5","volume":"7","author":"Y Acosta-Ampudia","year":"2018","unstructured":"Acosta-Ampudia Y, Monsalve DM, Rodr\u00edguez Y et al (2018) Mayaro: An emerging viral threat? Emerg Microbes Infect 7(1):1\u201311. https:\/\/doi.org\/10.1038\/s41426-018-0163-5","journal-title":"Emerg Microbes Infect"},{"issue":"2","key":"5020_CR124","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1002\/ski2.20","volume":"1","author":"S Schwartzberg Ln, Advani","year":"2021","unstructured":"Schwartzberg Ln, Advani S, Clancy Dc et al (2021) A systematic review of dermatologic manifestations among adult patients with COVID-19 diagnosis. Skin Health Dis 1(2):e20. https:\/\/doi.org\/10.1002\/ski2.20","journal-title":"Skin Health Dis"},{"issue":"8","key":"5020_CR125","doi-asserted-by":"publisher","first-page":"e01982","DOI":"10.1128\/jvi.01982-18","volume":"93","author":"N-N Zhang","year":"2019","unstructured":"Zhang N-N, Zhang L, Deng Y-Q et al (2019) Zika virus infection in Tupaia belangeri causes dermatological manifestations and confers protection against secondary infection. J Virol 93(8):e01982\u2013e01918. https:\/\/doi.org\/10.1128\/jvi.01982-18","journal-title":"J Virol"},{"issue":"3","key":"5020_CR126","doi-asserted-by":"publisher","first-page":"e2287","DOI":"10.1002\/rmv.2287","volume":"32","author":"KN Manzoor","year":"2022","unstructured":"Manzoor KN, Javed F, Ejaz M et al (2022) The global emergence of chikungunya infection: An integrated view. Rev Med Virol 32(3):e2287. https:\/\/doi.org\/10.1002\/rmv.2287","journal-title":"Rev Med Virol"},{"issue":"3","key":"5020_CR127","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.47009\/jamp.2023.5.3.325","volume":"5","author":"M Srinath","year":"2023","unstructured":"Srinath M, Sultana W, Rani VS et al (2023) Co-infection of COVID-19 with dengue and Chikungunya: A study from a tertiary care hospital. JAMP 5(3):1620\u20131622. https:\/\/doi.org\/10.47009\/jamp.2023.5.3.325","journal-title":"JAMP"},{"issue":"5","key":"5020_CR128","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.bjid.2020.07.008","volume":"24","author":"N Bicudo","year":"2020","unstructured":"Bicudo N, Bicudo E, Costa JD et al (2020) Co-infection of SARS-CoV-2 and dengue virus: a clinical challenge. Braz J Infect Dis 24(5):452\u2013454. https:\/\/doi.org\/10.1016\/j.bjid.2020.07.008","journal-title":"Braz J Infect Dis"},{"key":"5020_CR129","doi-asserted-by":"publisher","unstructured":"Schulte HL, Brito-Sousa JD, Lacerda MVG et al (2021) SARS-CoV-2\/DENV co-infection: A series of cases from the Federal District, Midwestern Brazil. BMC Infect Dis 21(727). https:\/\/doi.org\/10.1186\/s12879-021-06456-2","DOI":"10.1186\/s12879-021-06456-2"},{"key":"5020_CR130","doi-asserted-by":"publisher","unstructured":"Carosella LM, Pryluka D, Maranzana A et al (2021) Characteristics of patients co-infected with severe acute respiratory syndrome coronavirus 2 and Dengue virus, Buenos Aires, Argentina, March\u2013June 2020. Emerg Infect Dis 27(2). https:\/\/doi.org\/10.3201\/eid2702.203439","DOI":"10.3201\/eid2702.203439"},{"key":"5020_CR131","doi-asserted-by":"publisher","first-page":"102132","DOI":"10.1016\/j.tmaid.2021.102132","volume":"43","author":"JL Mej\u00eda-Parra","year":"2021","unstructured":"Mej\u00eda-Parra JL, Aguilar-Martinez S, Fern\u00e1ndez-Mogoll\u00f3n JL et al (2021) Characteristics of patients coinfected with severe acute respiratory syndrome coronavirus 2 and dengue virus, Lambayeque, Peru, May\u2013August 2020: A retrospective analysis. Travel Med Infect Dis 43:102132. https:\/\/doi.org\/10.1016\/j.tmaid.2021.102132","journal-title":"Travel Med Infect Dis"},{"issue":"3","key":"5020_CR132","doi-asserted-by":"publisher","first-page":"536","DOI":"10.4269\/ajtmh.22-0717","volume":"109","author":"OL Agudelo-Rojas","year":"2023","unstructured":"Agudelo-Rojas OL, Rebell\u00f3n-S\u00e1nchez DE, Torres JL et al (2023) Co-Infection between Dengue Virus and SARS-CoV-2 in Cali, Colombia. Am J Trop Med Hyg 109(3):536\u2013541. https:\/\/doi.org\/10.4269\/ajtmh.22-0717","journal-title":"Am J Trop Med Hyg"},{"key":"5020_CR133","doi-asserted-by":"publisher","unstructured":"Teot\u00f4nio IMSN, Carvalho JLd, Castro LC et al (2021) Clinical and biochemical parameters of COVID-19 patients with prior or active dengue fever. Acta Trop 214. https:\/\/doi.org\/10.1016\/j.actatropica.2020.105782","DOI":"10.1016\/j.actatropica.2020.105782"},{"issue":"4","key":"5020_CR134","doi-asserted-by":"publisher","first-page":"e0265820","DOI":"10.1371\/journal.pone.0265820","volume":"17","author":"Y Tarazona-Castro","year":"2022","unstructured":"Tarazona-Castro Y, Troyes-Rivera L, Martins-Luna J et al (2022) Detection of SARS-CoV-2 antibodies in febrile patients from an endemic region of dengue and chikungunya in Peru. PLoS ONE 17(4):e0265820. https:\/\/doi.org\/10.1371\/journal.pone.0265820","journal-title":"PLoS ONE"},{"issue":"5","key":"5020_CR135","doi-asserted-by":"publisher","first-page":"e2339","DOI":"10.1002\/rmv.2339","volume":"32","author":"AE El-Qushayri","year":"2022","unstructured":"El-Qushayri AE, Kamel AMA, Reda A, Ghozy S (2022) Does dengue and COVID\u201019 co\u2010infection have worse outcomes? A systematic review of current evidence. Rev Med Virol 32(5):e2339. https:\/\/doi.org\/10.1002\/rmv.2339","journal-title":"Rev Med Virol"},{"issue":"1","key":"5020_CR136","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1186\/s12879-021-06765-6","volume":"21","author":"PMM Jose","year":"2021","unstructured":"Jose PMM, Paola ZS, Eduardo DG et al (2021) A case of coinfection of a pediatric patient with acute SARS-CoV-2 with MIS-C and severe DENV-2 in Mexico: A case report. BMC Infect Dis 21(1):1072. https:\/\/doi.org\/10.1186\/s12879-021-06765-6","journal-title":"BMC Infect Dis"},{"key":"5020_CR137","doi-asserted-by":"publisher","unstructured":"Jakhar K, Sonar S, Singh G et al (2024) SARS-CoV-2 spike antibodies cross-react with dengue virus and enhance infection in-vitro and in-vivo. https:\/\/www.biorxiv.org\/content\/https:\/\/doi.org\/10.1101\/2023.10.09.557914v2. Accessed 2024\/09\/12","DOI":"10.1101\/2023.10.09.557914v2"},{"key":"5020_CR138","doi-asserted-by":"publisher","unstructured":"Sarker S, Dutta C, Mallick A et al (2024) Dengue virus (DV) non-cross-reactive Omicron wave COVID-19 serums enhanced DV3 infectivity in vitro. J Med Microbiol 73(7). https:\/\/doi.org\/10.1099\/jmm.0.001852","DOI":"10.1099\/jmm.0.001852"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-026-05020-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-026-05020-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-026-05020-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T09:15:08Z","timestamp":1784798108000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00284-026-05020-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":138,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["5020"],"URL":"https:\/\/doi.org\/10.1007\/s00284-026-05020-y","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"13 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"449"}}